Janney Upgrades Amicus Therapeutics (FOLD) to Buy

Janney Montgomery Scott upgraded Amicus Therapeutics (NASDAQ: FOLD) from Neutral to Buy with a price target of $5.00 (from $2.50).

For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.

Shares of Amicus Therapeutics closed at $3.34 yesterday.

You May Also Be Interested In

• Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
• Evercore ISI Upgrades CIENA (CIEN) to Outperform, 'we think the guide is conservative and we see a path to >40% growth'
• BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy